MetLife Investment Management, LLC
Position in CATX — Perspective Therapeutics, Inc.
CIK 1529735
Whippany, NJ
Position in CATX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$137,939
+$91,968 QoQ
Shares Held
33,079
+97.9% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $252,892,049 across 66 Medical Devices names. CATX ranks #52 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
406,187 | $41,703,219 | |
| 2 | SYK |
Stryker Corp
|
84,470 | $27,755,997 | |
| 3 | MDT |
Medtronic plc
|
299,560 | $25,956,874 | |
| 4 | BSX |
Boston Scientific Corp
|
357,894 | $22,457,848 | |
| 5 | GMED |
Globus Medical Inc
|
247,619 | $21,334,853 | |
| 6 | BRKR |
Bruker Corp
|
475,733 | $17,183,475 | |
| 7 | ATEC |
Alphatec Holdings, Inc.
|
1,327,843 | $14,446,931 | |
| 8 | EW |
Edwards Lifesciences Corp
|
135,513 | $10,851,881 |
All Filings in CATX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $137,939 | 33,079 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $45,971 | 16,717 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $101,387 | 29,559 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $108,542 | 31,553 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $66,690 | 31,310 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $70,907 | 22,228 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $416,052 | 31,165 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $119,919 | 12,028 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||